Michael Vincent Meluzio - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Michael Vincent Meluzio has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Michael Vincent Meluzio is a corporate insider at Cue Biopharma, Inc. (CUE). Meluzio has reported 1 insider filing with the SEC since 2026. The most recent filing was in July 2026.
| Role | VP, Prin. Accounting Officer |
|---|---|
| Notability | 20/100 |
Board memberships
- Cue Biopharma, Inc.
Awards & honors
- Associated with Cue Biopharma, Inc. per SEC filings (as of 2026-07-10)
Trading Pattern
InsiderAlpha's records for Michael Vincent Meluzio go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Michael Vincent Meluzio has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- VP, Prin. Accounting Officer at Cue Biopharma, Inc. (CUE) - 1 filing, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | CUE | Cue Biopharma, Inc. | A - Grant or award | 40.9K | $0.00 |
Companies - Last 90 Days
- Cue Biopharma, Inc. (CUE) - 1 filing, last 2026-07-10
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Michael Vincent Meluzio has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $1000K of CUE open-market activity in the last 12 months
- Pasha Sarraf - $100K of CUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Andrew J. Mills
- Charles N. Mills
- Kevin J. Mills
- Mink Brook Asset Management LLC
- Shankh Mitra
- MITSUI SUMITOMO INSURANCE CO LTD
- Arturo R. Moreno
- Matthew T. Moroun
Frequently Asked Questions
Who is Michael Vincent Meluzio?
Michael Vincent Meluzio is a corporate insider at Cue Biopharma, Inc. (CUE). Meluzio has reported 1 insider filing with the SEC since 2026. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Michael Vincent Meluzio submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Michael Vincent Meluzio's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Michael Vincent Meluzio profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.